InVivo Therapeutics Holdings Corp. Stock News

California law aims to require full disclosure online — but there’s an exception that consumer groups want eliminated

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-30 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipat

The Calgary chapter of Safari Club International is selling a licence to kill an elephant in Botswana, and a country that was leading the way in conservation is again back to killing wildlife for plea

Le discours des professionnels du patrimoine est connu : en résumé, le fonds en euros ne rapporte plus rien, il est urgent de diversifier votre contrat d’assurance vie multisupport en Bourse

Invivo Therapeutics (NASDAQ:NVIV) and SI-Bone (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of thei

Patient scheduling is increasingly seen as a key part of revenue cycle management. It also can help create a more welcoming "digital front door" that improves access to care and the overall patient ex

Rupee finally settled at 71.74, registering a loss of 3 paise over its previous close.

InVivo Therapeutics Holdings Corp. (NVIV) today announced the closing of its previously announced public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a price to t

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alny

InVivo Therapeutics Holdings Corp. (NVIV) today announced the pricing of a public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a price to the public of $0.12 per

InVivo Therapeutics Holdings Corp. (NVIV) today announced that it has commenced a proposed public offering of shares of its common stock, par value $0.00001 per share. The proposed public offering is

InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Robert J. Rosenthal, Ph.D., to the Company’s Board of Directors, effective November 8, 2019. Dr. Rosenthal brings more t

The CEO of PixarBio Corp., a biopharma startup founded in Massachusetts, has been found guilty of defrauding hundreds of investors out of approximately $12.7 million.

Three-high ranking members of the Pagans, including the reputed vice president of the national organization, Hugo Nieves, were subpoenaed to testify.

InVivo Therapeutics Holdings Corp. (NVIV) today announced that a total of five patients have been enrolled into The INSPIRE 2.0 Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™